The serum concentration of the calcium binding protein S100B is positively associated with cognitive performance in older adults

Frontiers in Aging Neuroscience

Volumn 5, Issue SEP, 2013, Pages

  Lam, Virginie ^a   Albrecht, Matthew A ^a   Takechi, Ryusuke ^a   Giles, Corey ^a   James, Anthony P ^a   Foster, Jonathan K ^a,b   Mamo, John C L ^a  

^a CURTIN UNIVERSITY   (Australia)

^b Neurosciences Unit   (Australia)

Author keywords

Alzheimer's disease; Bayesian analysis; Neuro inflammation; Neuropsychological measures; S100B

Indexed keywords

PROTEIN S100B;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BOSTON NAMING TEST; CALCIUM BLOOD LEVEL; DELIS KAPLAN EXECUTIVE FUNCTION SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL ADULT READING TEST; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RECALL; RECOGNITION; RESPONSE TIME; SENESCENCE; SEX DIFFERENCE; STROOP TEST; TASK PERFORMANCE; VERY ELDERLY; WECHSLER INTELLIGENCE SCALE;

EID: 84895780346     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00061     Document Type: Article

References (35)

1. Backman, L., Jones, S., Berger, A. K., Laukka, E. J., and Small, B. J. (2004). Multiple cognitive deficits during the transition to Alzheimer's disease. J. Intern. Med. 256, 195-204. doi: 10.1111/j.1365-2796.2004.01386.x.
2. Bianchi, R., Adami, C., Giambanco, I., and Donato, R. (2007). S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 81, 108-118. doi:10.1189/jlb.0306198.
3. Delis, D. C., Kaplan, E., and Kramer, J. H. (2001). Delis-Kaplan Executive Function. San Antonio: The Psychological Corporation.
4. Donato, R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668. doi:10.1016/S1357-2725(01)00046-2.
5. Ellis, E. F., Willoughby, K. A., Sparks, S. A., and Chen, T. (2007). S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons. J. Neurochem. 101, 1463-1470. doi:10.1111/j.1471-4159.2007.04515.x.
6. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198. doi:10.1016/0022-3956(75)90026-6.
7. Gelman, A. (2006). Prior distributions for variance parameters in hierarchical models. Bayesian Anal. 1, 515-533. doi:10.1214/06-BA117A.
8. Gelman, A., Hill, J., and Yajima, M. (2012). Why we (usually) don't have to worry about multiple comparisons. J. Res. Educ. Eff. 5, 189-211. doi:10.1080/19345747.2011.618213.
9. Gelman, A., and Rubin, D. B. (1992). Inference from iterative simulation using multiple sequences. Stat. Sci. 7, 457-511. doi:10.1214/ss/1177011136.
10. Green, A. J., Harvey, R. J., Thompson, E. J., and Rossor, M. N. (1997). Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia. Neurosci. Lett. 235, 5-8.
11. Heizmann, C. W. (2002). The multifunctional S100 protein family. Methods Mol. Biol. 172, 69-80.
12. Huttunen, H. J., Fages, C., and Rauvala, H. (1999). Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924. doi:10.1074/jbc.274.28.19919.
13. Jonsson, H., Johnsson, P., Hoglund, P., Alling, C., and Blomquist, S. (2000). Elimination of S100B and renal function after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 14, 698-701. doi:10.1053/jcan.2000.18444.
14. Kleindienst, A., McGinn, M. J., Harvey, H. B., Collelo, R. J., Hamm, R. J., and Bullock, M. R. (2005). Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. J. Neurotrauma 22, 645-655. doi:10.1089/neu.2005.22.645.
15. Kruschke, J. K. (2012). Bayesian estimation supersedes the t test. J. Exp. Psychol. Gen. 142, 573-603. doi:10.1037/a0029146.
16. Lange, K. L., Little, R. J. A., and Taylor, J. M. G. (1989). Robust statistical modeling using the t distribution. J. Am. Stat. Assoc. 84, 881-896. doi:10.2307/2290063.
17. Lezak, M. D., Howieson, D. B., and Loring, D. W. (2004). Neuropsychological Assessment. New York: Oxford University Press.
18. Marchi, N., Rasmussen, P., Kapural, M., Fazio, V., Kight, K., Mayberg, M. R., et al. (2003). Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor. Neurol. Neurosci. 21, 109-121.
19. Moore, B. W. (1965). A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19, 739-744. doi:10.1016/0006-291X(65)90320-7.
20. Nelson, H. E., and Willison, J. R. (1991). The Revised National Adult Reading Test-Test Manual. Windsor: NFER-Nelson.
21. Nooijen, P. T., Schoonderwaldt, H. C., Wevers, R. A., Hommes, O. R., and Lamers, K. J. (1997). Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia. Dement. Geriatr. Cogn. Disord. 8, 169-173. doi:10.1159/000106627.
22. Peskind, E. R., Griffin, W. S., Akama, K. T., Raskind, M. A., and Van Eldik, L. J. (2001). Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem. Int. 39, 409-413. doi:10.1016/S0197-0186(01)00048-1.
23. Plummer, M. (2013). Rjags: Bayesian Graphical Models Using MCMC. R Package Version 3-11. Available at: http://CRAN.R-project.org/package=rjags.
24. Salthouse, T. A. (1996). The processing-speed theory of adult age differences in cognition. Psychol. Rev. 103, 403-428. doi:10.1037/0033-295X.103.3.403.
25. Saxton, J., Ratcliff, G., Munro, C. A., Coffey, E. C., Becker, J. T., Fried, L., et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin. Neuropsychol. 14, 526-534. doi:10.1076/clin.14.4.526.7204.
26. Schaf, D. V., Tort, A. B., Fricke, D., Schestatsky, P., Portela, L. V., Souza, D. O., et al. (2005). S100B and NSE serum levels in patients with Parkinson's disease. Parkinsonism Relat. Disord. 11, 39-43. doi:10.1016/j.parkreldis.2004.07.002.
27. Selinfreund, R. H., Barger, S. W., Pledger, W. J., and Van Eldik, L. J. (1991). Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88, 3554-3558. doi:10.1073/pnas.88.9.3554.
28. Sen, J., and Belli, A. (2007). S100B in neuropathologic states: the CRP of the brain? J. Neurosci. Res. 85, 1373-1380. doi:10.1002/jnr.21211.
29. Smith, S. P., Barber, K. R., Dunn, S. D., and Shaw, G. S. (1996). Structural influence of cation binding to recombinant human brain S100b: evidence for calcium-induced exposure of a hydrophobic surface. Biochemistry 35, 8805-8814. doi:10.1021/bi952698c.
30. Sorci, G., Agneletti, A. L., Bianchi, R., and Donato, R. (1998). Association of S100B with intermediate filaments and microtubules in glial cells. Biochim. Biophys. Acta 1448, 277-289. doi:10.1016/S0167-4889(98)00134-7.
31. Strauss, E., Sherman, E., and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford University Press.
32. Thurston, S. W., Ruppert, D., and Davidson, P. W. (2009). Bayesian models for multiple outcomes nested in domains. Biometrics 65, 1078-1086. doi:10.1111/j.1541-0420.2009.01224.x.
33. Wechsler, D., and Scale, W. (1997). WAIS-III/WMS-III Technical Manual. San Antonio: The Psychological Corporation.
34. Weintraub, S., Wicklund, A. H., and Salmon, D. P. (2012). The neuropsychological profile of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006171. doi:10.1101/cshperspect.a006171.
35. Yardan, T., Erenler, A. K., Baydin, A., Aydin, K., and Cokluk, C. (2011). Usefulness of S100B in neurological disorders. J. Pak. Med. Assoc. 61, 276-281.